Advanced Search

Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2013 June;65(2) > Minerva Urologica e Nefrologica 2013 June;65(2):85-92

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,965

Frequency: Quarterly

ISSN 0393-2249

Online ISSN 1827-1758

Minerva Urologica e Nefrologica 2013 June;65(2):85-92

EXPERTS IN STONE DISEASE 

Stents and stone disease

Van Der Merwe A. 1, Van Heerden H. 1, Bonkat G. 2, Heyns C. 1

1 Department Urology, Stellenbosch University Cape Town, South Africa;
2 Department Urology, Basel University Basel, Switzerland

The use of stents in renal stone disease is relatively new. The main advantage is reduced pressure in the renal collecting system during times of infected obstructed collecting systems, surgery or obstructing stones. As much pain relieve theses stents offer when indicated, equally much morbidity is caused when stent materials interface with the human urothelium in terms of symptoms, perforations and the “forgotten stent”. This review aim to summarize some of the most important considerations when stents are used in stone disease.

language: English


FULL TEXT  REPRINTS

top of page